Market Research Report

Classical Swine Fever Live Vaccine Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-19443
  • CAT ID : 7
  • Pages : 156
  • Date : Jun 2023
 

The global Classical Swine Fever Live Vaccine market was valued at US$ 159.2 million in 2022 and is projected to reach US$ 215.2 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tissue Culture Origin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Classical Swine Fever Live Vaccine include WINSUN, Boehringer Ingelheim, CAHIC, SPAH, Merck, Ceva, Harbin Veterinary Research Institute, Qilu Animal Health Products Factory and Ringpu Biology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
This report aims to provide a comprehensive presentation of the global market for Classical Swine Fever Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Classical Swine Fever Live Vaccine. This report contains market size and forecasts of Classical Swine Fever Live Vaccine in global, including the following market information:
Global Classical Swine Fever Live Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Classical Swine Fever Live Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Classical Swine Fever Live Vaccine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Classical Swine Fever Live Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Classical Swine Fever Live Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Classical Swine Fever Live Vaccine Market Segment Percentages, by Type, 2022 (%)
Tissue Culture Origin
Cell Line Origin
Global Classical Swine Fever Live Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Classical Swine Fever Live Vaccine Market Segment Percentages, by Application, 2022 (%)
Market Sales
Government Tender
Global Classical Swine Fever Live Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Classical Swine Fever Live Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Classical Swine Fever Live Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Classical Swine Fever Live Vaccine revenues share in global market, 2022 (%)
Key companies Classical Swine Fever Live Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Classical Swine Fever Live Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
WINSUN
Boehringer Ingelheim
CAHIC
SPAH
Merck
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Outline of Major Chapters:
Chapter 1: Introduces the definition of Classical Swine Fever Live Vaccine, market overview.
Chapter 2: Global Classical Swine Fever Live Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Classical Swine Fever Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Classical Swine Fever Live Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Classical Swine Fever Live Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Classical Swine Fever Live Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Classical Swine Fever Live Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Classical Swine Fever Live Vaccine Overall Market Size
2.1 Global Classical Swine Fever Live Vaccine Market Size: 2022 VS 2029
2.2 Global Classical Swine Fever Live Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Classical Swine Fever Live Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Classical Swine Fever Live Vaccine Players in Global Market
3.2 Top Global Classical Swine Fever Live Vaccine Companies Ranked by Revenue
3.3 Global Classical Swine Fever Live Vaccine Revenue by Companies
3.4 Global Classical Swine Fever Live Vaccine Sales by Companies
3.5 Global Classical Swine Fever Live Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Classical Swine Fever Live Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Classical Swine Fever Live Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Classical Swine Fever Live Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Classical Swine Fever Live Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Classical Swine Fever Live Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Classical Swine Fever Live Vaccine Market Size Markets, 2022 & 2029
4.1.2 Tissue Culture Origin
4.1.3 Cell Line Origin
4.2 By Type - Global Classical Swine Fever Live Vaccine Revenue & Forecasts
4.2.1 By Type - Global Classical Swine Fever Live Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Classical Swine Fever Live Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Classical Swine Fever Live Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Classical Swine Fever Live Vaccine Sales & Forecasts
4.3.1 By Type - Global Classical Swine Fever Live Vaccine Sales, 2018-2023
4.3.2 By Type - Global Classical Swine Fever Live Vaccine Sales, 2024-2029
4.3.3 By Type - Global Classical Swine Fever Live Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Classical Swine Fever Live Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Classical Swine Fever Live Vaccine Market Size, 2022 & 2029
5.1.2 Market Sales
5.1.3 Government Tender
5.2 By Application - Global Classical Swine Fever Live Vaccine Revenue & Forecasts
5.2.1 By Application - Global Classical Swine Fever Live Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Classical Swine Fever Live Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Classical Swine Fever Live Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Classical Swine Fever Live Vaccine Sales & Forecasts
5.3.1 By Application - Global Classical Swine Fever Live Vaccine Sales, 2018-2023
5.3.2 By Application - Global Classical Swine Fever Live Vaccine Sales, 2024-2029
5.3.3 By Application - Global Classical Swine Fever Live Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Classical Swine Fever Live Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Classical Swine Fever Live Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Classical Swine Fever Live Vaccine Revenue & Forecasts
6.2.1 By Region - Global Classical Swine Fever Live Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Classical Swine Fever Live Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Classical Swine Fever Live Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Classical Swine Fever Live Vaccine Sales & Forecasts
6.3.1 By Region - Global Classical Swine Fever Live Vaccine Sales, 2018-2023
6.3.2 By Region - Global Classical Swine Fever Live Vaccine Sales, 2024-2029
6.3.3 By Region - Global Classical Swine Fever Live Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Classical Swine Fever Live Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Classical Swine Fever Live Vaccine Sales, 2018-2029
6.4.3 US Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.4.4 Canada Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.4.5 Mexico Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Classical Swine Fever Live Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Classical Swine Fever Live Vaccine Sales, 2018-2029
6.5.3 Germany Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.5.4 France Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.5.5 U.K. Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.5.6 Italy Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.5.7 Russia Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.5.9 Benelux Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Classical Swine Fever Live Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Classical Swine Fever Live Vaccine Sales, 2018-2029
6.6.3 China Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.6.4 Japan Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.6.5 South Korea Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.6.7 India Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Classical Swine Fever Live Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Classical Swine Fever Live Vaccine Sales, 2018-2029
6.7.3 Brazil Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.7.4 Argentina Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Classical Swine Fever Live Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Classical Swine Fever Live Vaccine Sales, 2018-2029
6.8.3 Turkey Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.8.4 Israel Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Classical Swine Fever Live Vaccine Market Size, 2018-2029
6.8.6 UAE Classical Swine Fever Live Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 WINSUN
7.1.1 WINSUN Company Summary
7.1.2 WINSUN Business Overview
7.1.3 WINSUN Classical Swine Fever Live Vaccine Major Product Offerings
7.1.4 WINSUN Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 WINSUN Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Classical Swine Fever Live Vaccine Major Product Offerings
7.2.4 Boehringer Ingelheim Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 CAHIC
7.3.1 CAHIC Company Summary
7.3.2 CAHIC Business Overview
7.3.3 CAHIC Classical Swine Fever Live Vaccine Major Product Offerings
7.3.4 CAHIC Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 CAHIC Key News & Latest Developments
7.4 SPAH
7.4.1 SPAH Company Summary
7.4.2 SPAH Business Overview
7.4.3 SPAH Classical Swine Fever Live Vaccine Major Product Offerings
7.4.4 SPAH Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 SPAH Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Classical Swine Fever Live Vaccine Major Product Offerings
7.5.4 Merck Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Ceva
7.6.1 Ceva Company Summary
7.6.2 Ceva Business Overview
7.6.3 Ceva Classical Swine Fever Live Vaccine Major Product Offerings
7.6.4 Ceva Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Ceva Key News & Latest Developments
7.7 Harbin Veterinary Research Institute
7.7.1 Harbin Veterinary Research Institute Company Summary
7.7.2 Harbin Veterinary Research Institute Business Overview
7.7.3 Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Major Product Offerings
7.7.4 Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Harbin Veterinary Research Institute Key News & Latest Developments
7.8 Qilu Animal Health Products Factory
7.8.1 Qilu Animal Health Products Factory Company Summary
7.8.2 Qilu Animal Health Products Factory Business Overview
7.8.3 Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Major Product Offerings
7.8.4 Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Qilu Animal Health Products Factory Key News & Latest Developments
7.9 Ringpu Biology
7.9.1 Ringpu Biology Company Summary
7.9.2 Ringpu Biology Business Overview
7.9.3 Ringpu Biology Classical Swine Fever Live Vaccine Major Product Offerings
7.9.4 Ringpu Biology Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Ringpu Biology Key News & Latest Developments
7.10 DHN
7.10.1 DHN Company Summary
7.10.2 DHN Business Overview
7.10.3 DHN Classical Swine Fever Live Vaccine Major Product Offerings
7.10.4 DHN Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 DHN Key News & Latest Developments
7.11 CAVAC
7.11.1 CAVAC Company Summary
7.11.2 CAVAC Classical Swine Fever Live Vaccine Business Overview
7.11.3 CAVAC Classical Swine Fever Live Vaccine Major Product Offerings
7.11.4 CAVAC Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 CAVAC Key News & Latest Developments
7.12 Komipharm
7.12.1 Komipharm Company Summary
7.12.2 Komipharm Classical Swine Fever Live Vaccine Business Overview
7.12.3 Komipharm Classical Swine Fever Live Vaccine Major Product Offerings
7.12.4 Komipharm Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Komipharm Key News & Latest Developments
7.13 Agrovet
7.13.1 Agrovet Company Summary
7.13.2 Agrovet Classical Swine Fever Live Vaccine Business Overview
7.13.3 Agrovet Classical Swine Fever Live Vaccine Major Product Offerings
7.13.4 Agrovet Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Agrovet Key News & Latest Developments
7.14 Bioveta
7.14.1 Bioveta Company Summary
7.14.2 Bioveta Business Overview
7.14.3 Bioveta Classical Swine Fever Live Vaccine Major Product Offerings
7.14.4 Bioveta Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Bioveta Key News & Latest Developments
7.15 Jinyu Bio-Technology
7.15.1 Jinyu Bio-Technology Company Summary
7.15.2 Jinyu Bio-Technology Business Overview
7.15.3 Jinyu Bio-Technology Classical Swine Fever Live Vaccine Major Product Offerings
7.15.4 Jinyu Bio-Technology Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Jinyu Bio-Technology Key News & Latest Developments
7.16 Institutul Pasteur
7.16.1 Institutul Pasteur Company Summary
7.16.2 Institutul Pasteur Business Overview
7.16.3 Institutul Pasteur Classical Swine Fever Live Vaccine Major Product Offerings
7.16.4 Institutul Pasteur Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Institutul Pasteur Key News & Latest Developments
7.17 MVP
7.17.1 MVP Company Summary
7.17.2 MVP Business Overview
7.17.3 MVP Classical Swine Fever Live Vaccine Major Product Offerings
7.17.4 MVP Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 MVP Key News & Latest Developments
7.18 Tecon
7.18.1 Tecon Company Summary
7.18.2 Tecon Business Overview
7.18.3 Tecon Classical Swine Fever Live Vaccine Major Product Offerings
7.18.4 Tecon Classical Swine Fever Live Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Tecon Key News & Latest Developments
8 Global Classical Swine Fever Live Vaccine Production Capacity, Analysis
8.1 Global Classical Swine Fever Live Vaccine Production Capacity, 2018-2029
8.2 Classical Swine Fever Live Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Classical Swine Fever Live Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Classical Swine Fever Live Vaccine Supply Chain Analysis
10.1 Classical Swine Fever Live Vaccine Industry Value Chain
10.2 Classical Swine Fever Live Vaccine Upstream Market
10.3 Classical Swine Fever Live Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Classical Swine Fever Live Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe